Viritis
Next-generation antisense-based antiviral treatments
StartupViritis is a Petah Tikva-based startup in the Health Tech & Life Sciences sector, established in 2023. Next-generation antisense-based antiviral treatments. The company has raised a total of $665K across 4 funding rounds, currently at the Pre-Seed stage. Viritis was founded by Aaron Wis, Amit Turman , Amit Philosoph. Key investors include Road2, Undisclosed Investor(s). The company has 1-10 employees. Core technologies: Artificial Intelligence, Materials & Substances, Nanomaterials, Biologicals, Cells, Molecules.
With $665K in total funding, Viritis is a Pre-Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D. The company holds 1 patent.
- StagePre-Seed
- ProductR&D
- ModelB2B
- Employees1-10
- HQPetah Tikva
- DistrictCenter District
- Last Round$500K
- Road2
- Undisclosed Investor(s)
Aaron WisChairman
Amit Turman Co-founder & CEO
Amit PhilosophChief Scientist
2 articles covered by sources including www.nature.com,
www.haaretz.com.
What does Viritis do?
Viritis is a biotech company pioneering a next-generation antisense-based platform for rapid development of antiviral drugs. Our novel technology targets all strains of a given virus, offering a scalable and precise solution for current and emerging viral threats. Our platform combines AI-driven algorithms with patented molecule design to bind specifically to viral RNA. Once attached, it activates the cell’s innate defense mechanisms, degrading the virus from within— without harming the host. After completing its function, the molecule naturally disintegrates within hours, leaving no harmful residues. In POC studies, our platform demonstrated 97.1% cellular protection against the target virus. Its innovative structure also makes it highly stable, can be lyophilize, and easy to store and transport—ideal for global deployment.
How much funding has Viritis raised?
Viritis has raised $665K in total funding across 4 rounds. The company is currently at the Pre-Seed stage. Key investors include Road2, Undisclosed Investor(s).
Who founded Viritis?
Viritis was founded in 2023 by Aaron Wis (Chairman), Amit Turman (Co-founder & CEO), Amit Philosoph (Chief Scientist).
What sector is Viritis in?
Viritis operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Artificial Intelligence, Materials & Substances, Nanomaterials, Biologicals, Cells, Molecules. Target customers: Healthcare & Life Sciences, Life Sciences, Biotechnology, Pharmaceuticals.
Where is Viritis located?
Viritis is based in Petah Tikva, Israel, Center District.